Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenocarcinoma of Lung × Cisplatin × Clear all

Phase

Phase 2 23 Phase 3 5 Phase 1 4 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Esophageal Neoplasms 7 Nasopharyngeal Carcinoma 6 Lung Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 4 Head and Neck Neoplasms 4 Cholangiocarcinoma 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Neoplasm Metastasis 3 Gallbladder Neoplasms 3 Carcinoma 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Mesothelioma 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Breast Neoplasms 2 Bile Duct Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1

Interventions

Taxes 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Pharmacogenomic Testing 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03380468 2023-07-20

ECTOP-1004

Fudan University

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡